| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83566 |
用于DNA/RNA递送的DDAB脂质体,定制服务 |
209 |
axc |
2024-12-23 |
| 83567 |
用于DNA/RNA递送的DC胆固醇脂质体,定制服务 |
211 |
axc |
2024-12-23 |
| 83568 |
Cl-C6-PEG6-NHCO-C3-NHS，氯-C6-六聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
271 |
h |
2024-12-23 |
| 83569 |
用于DNA/RNA递送的GL-67脂质体,定制服务 |
236 |
axc |
2024-12-23 |
| 83570 |
cas:1824718-79-7，SPDH，N-succinimidyl-6-(2-pyridyldithio)capronate-ADC连接子 |
188 |
zyl |
2024-12-23 |
| 83571 |
标准氯膦酸盐脂质体试剂盒(阴离子，含有对照脂质体)，Standard Clodronate Liposomes Kits (Anionic, contain control liposomes) |
529 |
axc |
2024-12-23 |
| 83572 |
Standard Clodronate Liposomes Kits (Neutral, contain control liposomes)，标准氯屈膦酸盐脂质体试剂盒（中性，含有对照脂质体） |
214 |
axc |
2024-12-23 |
| 83573 |
cas:890409-85-5，2,5-dioxopyrrolidin-1-yl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate |
208 |
zyl |
2024-12-23 |
| 83574 |
标准普通对照脂质体(阴离子),Standard Plain Control Liposomes (Anionic) |
267 |
axc |
2024-12-23 |
| 83575 |
Tetrazine-Ph-NHCO-C3-NHS ester，四嗪-PH-NHCO-C3-琥珀酰亚胺酯,1244040-64-9 |
216 |
h |
2024-12-23 |
| 83576 |
cas:452072-27-4 Sulfo-SPP-可作ADC的连接剂 |
136 |
zyl |
2024-12-23 |
| 83577 |
标准氯膦酸盐脂质体(阴离子),Standard Clodronate Liposomes (Anionic) |
178 |
axc |
2024-12-23 |
| 83578 |
Boc-NH-PEG12-C3-acid，BOC-氨基-十二乙二醇-C3-羧酸 |
170 |
h |
2024-12-23 |
| 83579 |
标准普通对照脂质体(中性),Standard Plain control Liposomes (Neutral) |
229 |
axc |
2024-12-23 |
| 83580 |
CAS号1628113-16-5 SPDB-sulfo-ADC抗体偶联药物 |
219 |
zyl |
2024-12-23 |
| 83581 |
Standard Clodronate Liposomes (Neutral),标准氯膦酸盐脂质体(中性) |
201 |
axc |
2024-12-23 |
| 83582 |
Standard-Clodronate-Liposomes，标准氯膦酸盐脂质体 |
240 |
axc |
2024-12-23 |
| 83583 |
cas:186023-44-9 Fmoc-Ala-Pro-OH |
180 |
zyl |
2024-12-23 |
| 83584 |
cas:1343407-91-9 Alloc-Val-Ala-PAB |
196 |
zyl |
2024-12-23 |
| 83585 |
cas:1394238-91-5 Fmoc-Val-Ala-PAB-ADC连接子 |
212 |
zyl |
2024-12-23 |
| 83586 |
甘露糖基氯膦酸盐脂质体试剂盒，Mannosylated Clodronate Liposome Kits |
212 |
axc |
2024-12-23 |
| 83587 |
cas:1884577-99-4 Boc-Val-Ala-PAB-ADC抗体偶联药物 |
217 |
zyl |
2024-12-23 |
| 83588 |
Boc-NH-PEG10-C3-acid，BOC-氨基-十乙二醇-C3-羧酸 |
187 |
h |
2024-12-23 |
| 83589 |
Control for Mannosylated Clodronate Liposomes，甘露糖基氯膦酸盐脂质体的控制 |
207 |
axc |
2024-12-23 |
| 83590 |
Boc-NH-PEG5-C3-acid，BOC-氨基-五乙二醇-C3-羧酸 |
177 |
h |
2024-12-23 |
| 83591 |
cas:1870916-87-2 Mal-Val-Ala-PAB-ADC连接子 |
268 |
zyl |
2024-12-23 |
| 83592 |
Azide-PEG7-CH2CH2CH2-COOtBu，叠氮PEG7-CH2CH2CH2-COOtBu |
179 |
h |
2024-12-23 |
| 83593 |
Azide-PEG3-CH2CH2CH2-COOtBu，叠氮PEG3-CH2CH2CH2-COOtBu |
200 |
h |
2024-12-23 |
| 83594 |
cas:1343476-44-7 Val-Ala-PAB-OH |
226 |
zyl |
2024-12-23 |
| 83595 |
Azide-PEG4-CH2CH2CH2-COOtBu，叠氮PEG4-CH2CH2CH2-COOtBu |
163 |
h |
2024-12-23 |
| 83596 |
甘露糖基化氯膦酸盐脂质体，Mannosylated-Clodronate-Liposomes |
208 |
axc |
2024-12-23 |
| 83597 |
Thiol-PEG4-t-butyl ester，CAS：564476-33-1 |
173 |
h |
2024-12-23 |
| 83598 |
Cy7.5-CONH-(C1-CONH-C2-Mal)-C4-DOTA，CY7.5标记的大环化合物 |
187 |
h |
2024-12-23 |
| 83599 |
冻干氯膦酸盐脂质体(阴离子)的质控品，Control for Lyophilized Clodronate Liposome (Anionic) |
239 |
axc |
2024-12-23 |
| 83600 |
cas:2762518-86-3 NHS ester-PEG4-Val-Cit-PAB-MMAE的合成方法 |
371 |
zyl |
2024-12-23 |
| 83601 |
cas:1350456-56-2 Fmoc-Val-Cit-PAB-MMAE-ADC抗体偶联药物 |
217 |
zyl |
2024-12-23 |
| 83602 |
cas:1869126-64-6 Azido-PEG4-Val-Cit-PAB-MMAE-ADC连接子 |
255 |
zyl |
2024-12-23 |
| 83603 |
Cis-[Pt-1,3-Propanediamine]-2-C4-Azide，1821165-96-1 |
179 |
h |
2024-12-23 |
| 83604 |
冻干氯膦酸盐脂质体(中性)的质控品，Control for lyophilized Clodronate Liposome (Neutral) |
170 |
axc |
2024-12-23 |
| 83605 |
Pomalidomide-NH-C4-NH-Boc，2093388-52-2 |
207 |
h |
2024-12-23 |
| 83606 |
DOTA-(COOt-Bu)3-C4-NH2，1402393-59-2 |
200 |
h |
2024-12-23 |
| 83607 |
cas:1613321-01-9 6-Azidohexanoyl-Val-Cit-PAB一种点击化学试剂 |
174 |
zyl |
2024-12-23 |
| 83608 |
冻干氯膦酸盐脂质体(阴离子)，Lyophilized Clodronate Liposomes (Anionic) |
210 |
axc |
2024-12-23 |
| 83609 |
Thalidomide-O-C4-acid，2169266-67-3 |
228 |
h |
2024-12-23 |
| 83610 |
Biotin-LC-LC-NHS，89889-52-1 |
160 |
h |
2024-12-23 |
齐岳微信公众号
官方微信
库存查询